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Few in vitro screening assays for biological activities of plant extracts consider the potential effect of the gastrointestinal system on orally
consumed plant extracts. Crude water and methanol extracts of Tarchonanthus camphoratus (wild camphor) and Agathosma betulina (‘buchu’)
were prepared and exposed to simulated gastric fluid and simulated intestinal fluid during dissolution studies to address this aspect. The crude
extracts and resulting simulated gastric fluid and simulated intestinal fluid products were screened for antimicrobial activity against Staphylo-
coccus aureus (ATCC 25923), Enterococcus faecalis (ATCC 29212), Escherichia coli (ATCC 25922) and Proteus vulgaris (ATCC 33420). The
T. camphoratus crude extract exhibited antimicrobial activity which was reduced after exposure to simulated gastric fluid. After exposure to
simulated intestinal fluid no antimicrobial activity was detected, which suggests chemical alteration or degradation of the active compounds. For
A. betulina, the crude water extract and simulated gastric fluid product exhibited no antimicrobial activity, while the simulated intestinal fluid
product exhibited antimicrobial activity. This suggests activation of antimicrobial constituents during exposure to simulated intestinal fluid. The
chemical composition profiles of the crude extracts and products were determined by means of liquid chromatography coupled to an ultraviolet
detector (LC-UV) and a mass spectrometer (LC-MS) to qualitatively assess the effect of exposure to simulated gastrointestinal conditions on the
chemical composition of the extracts. In many cases, the peak area of compounds decreased after exposure to simulated gastric fluid and simulated
intestinal fluid, while the peak area of other compounds increased. Thus, it can be deduced that the antimicrobial activity and chemical
composition was altered after exposure to intestinal conditions during dissolution studies.
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In South Africa, a country rich in plant diversity,
approximately 3000 of the 30000 species of higher plants are
used for medicinal purposes, many of which are endemic to the
region. Of these, approximately 350–500 species are commonly
used and traded in large quantities as medicines (Steenkamp
et al., 2006). Both Tarchonanthus camphoratus L. (wild cam-
phor bush) and Agathosma betulina (Bergius) Pill. (round leaf
‘buchu’) are indigenous South African plants and have been
used extensively as part of a traditional herbal therapy to treat
various diseases. T. camphoratus (Asteraceae), is a shrub or
small tree that has a grayish appearance, hence the Afrikaans⁎ Corresponding author. Tel.: +27 12 382 6360; fax: +27 12 382 6243.
E-mail address: viljoenam@tut.ac.za (A.M. Viljoen).
0254-6299/$ - see front matter © 2009 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2009.02.180vernacular name (“vaal” = gray, “bos” = bush). Infusions and
tinctures of the leaves and twigs are used to treat gastrointestinal
conditions including abdominal pain, headache, toothache,
asthma, coughing, bronchitis and inflammation. The fresh or
dried plants are burnt and the smoke or fumes are inhaled to
treat asthma, headache, blocked sinuses, and rheumatism.
Historically, the Khoi and San people smoked the dried leaves
like tobacco, apparently with a slightly narcotic effect. A.
betulina (Rutaceae) is an evergreen, multi-stemmed, perennial,
woody shrub and is restricted in its natural distribution to the
sandy mountain slopes of the Western Cape Province. ‘Buchu’
has remained one of the most popular herbal medicines in South
Africa, with a reputation for treating kidney and urinary tract
infections, stomach ailments, gout, for the symptomatic relief of
rheumatism, and also for external application on wounds and
bruises (Van Wyk et al., 1997).ts reserved.
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a renewed interest in ethnopharmacological research worldwide.
Studies are generally of a screening nature and investigate
biological activities such as antioxidant, antibacterial, anti-
inflammatory and antifungal properties of extracts frommedicinal
plants usually based on ethnobotanical leads. The effect that the
gastrointestinal environment may have on these orally consumed
extracts is usually not explored even though it is well-known and
accepted in biopharmaceutics that the gastrointestinal system
plays a considerable part in the ultimate bioavailability of
conventional medicines (Ashford, 2007; Hamman, 2007). It is a
reasonable assumption that the same would apply to orally
consumed herbal medicines. The human gastrointestinal tract
transforms orally consumed substances into absorbablemolecules
and waste products by means of a digestive process. The fluids
present in the gastrointestinal system contain various substances
and enzymeswhich aids in the digestion process. The stomach has
a pHbetween 1 and 2 due to the secretion of hydrochloric acid and
contains the digestive enzyme pepsin. The pH of the small
intestine ranges between 5.1 and 7.5 and contains numerous
digestive enzymes (Mader, 1996; Hamman, 2007). It is well
documented that some active pharmaceutical ingredients have to
be protected, e.g. through enteric coating, against this harsh
environment in order to be effective. The presence of hydro-
chloric acid and enzymes in the stomach can easily cause acid or
enzyme catalysed hydrolysis of orally consumed compounds
thereby resulting in chemical modification and inactivation. Pre-
systemic metabolism and degradation in the gastrointestinal tract
primarily results in reducing the bioavailability of medicines.
However, in the case of pro-drugs these processes are essential for
the active parent drug to become available for absorption.
Medicines such as erythromycin stearate depend on degradation
in the gastrointestinal tract to release the therapeutically active
parent molecule. It exhibits limited solubility in gastric fluid but
dissolves and dissociates readily in the intestinal fluid, liberating
the free basewhich is absorbed (Proudfoot, 1996; Ashford, 2007).
In this study the potential effect of the gastrointestinal system on
various extracts was investigated by subjecting the extracts of two
important South African medicinal plants to simulated gastro-
intestinal conditions.
2. Materials and methods
2.1. Plant material
A. betulina leaves (dried) were purchased at a community
pharmacy and the aerial parts of T. camphoratus was collected
at the Walter Sisulu Botanical Garden and the leaves were air-
dried. Voucher specimens (AV 961 and AV 1395) were depos-
ited in the Department of Pharmaceutical Sciences, Tshwane
University of Technology.
2.2. Extract and final product preparation
The dried plant material was ground to a fine powder and
extracted with water and methanol. Extraction of the material was
conducted in a water bath (Scientific 32 l) at 40 °C for 3 h. Thiswas repeated three times to maximise extraction efficiency. The
methanol extracts were dried by evaporation and the water
extractswere freeze-dried (JouanLP3 freeze-drier). These extracts
were subjected to simulated gastrointestinal conditions using a
six-station Pharmatest Type PTW 5 dissolution apparatus set up
according to the British Pharmacopoeia (BP, 1988) specifications.
The paddle apparatus was set to 37 °C with a paddle speed of
150 rpm. Simulated gastric fluid (SGF) and simulated intestinal
fluid (SIF) were prepared as prescribed in the United States
Pharmacopoeia (USP, 1990). However, the composition of the
SGF was slightly altered for this study. Hydrochloric acid was
replaced with trifluoroacetic acid (TFA) (Sigma Aldrich) as it is
volatile thereby eliminating the possible interference of hydro-
chloric acid with subsequent antimicrobial experiments. The
experimental procedures and gastrointestinal fluids are also used
in dissolution experiments on conventional medicines. The
dissolution times of 2 h for the gastric simulation (stomach) and
6 h for the intestinal simulation (small intestines) were selected to
simulate the transit time of orally consumed substances in the
respective gastrointestinal segments. Agitation of the dissolution
media with the paddle simulated the normal peristalticmovements
of the gastrointestinal tract. After 900 ml of dissolution medium
were added to the dissolution flasks and the temperature was
stabilised at 37 °C, the paddles were lowered and 500 mg of each
plant extract were added to the different gastrointestinal fluids.
After the appropriate time for each simulated fluid had elapsed the
total contents of the flasks were dried by evaporation. The extracts
were re-dissolved in 30 ml of distilled water, 10 ml of methanol
were added and sonicated (Sonorex digital 10p) for 10 min at
37 °C and 100% power to dissolve solids. Proteins (added as
enzymes in the simulated fluids) were removed by complexation
with the addition of 30ml of acetonitrile placed in flasks in a water
bath (Scientific 32 l) at 60 °C for 10 min. The products were
filtered (Whatman® no. 41) and dried by evaporation. For each
plant, a crude water and methanol extract, a water and methanol
SGF product and a water andmethanol SIF product were obtained
for testing purposes.
2.3. Antimicrobial activity
The minimum inhibitory concentration (MIC) for each sample
was determined using the micro-titre plate method (Eloff, 1998).
Samples were screened against two Gram-positive bacteria, Sta-
phylococcus aureus (ATCC 25923) and Enterococcus faecalis
(ATCC 29212) and two Gram-negative bacteria, Escherichia coli
(ATCC 25922) and Proteus vulgaris (ATCC 33420). Pathogen
selection was undertaken on the basis of commonly occurring
infectants of the gastrointestinal tract. Microbial suspensions in
Tryptone Soya broth (TSB) were prepared according to a
McFarland No. 0.5 standard (approximately 1×108 CFU/ml).
The plant extracts were dissolved in sterile water to a concen-
tration of 64 mg/ml. The T. camphoratusmethanol extract did not
dissolve completely in water and was subsequently dissolved in
dimethylsulfoxide (DMSO) and sterile water (1:1). The 96-well
micro-titre plateswere aseptically prepared in a horizontal laminar
air flow cabinet. Sterile water aliquots (100 µl) were pipetted into
all the wells and 100 µl of each test sample were added to the top
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to obtain concentrations ranging from 16–0.125 mg/ml. The
bacterial culture (100 µl) was added to all wells, except the TSB
control row. A sterile film was used to cover all the wells to
eliminate evaporation and the plates were incubated at 37 °C for
24 h. As an indicator of bacterial growth, 40 µl of a 0.4 mg/ml p-
iodonitrotetrazolium violet (INT) solution (Sigma Aldrich) was
added to all the wells and left for 6 h to develop. The minimum
inhibitory concentration (MIC) was defined as the lowest concen-
tration that inhibited growth of the microorganism detected
visually, that is a well that shows no red discolouration (Matasyoh
et al., 2007). The broad-spectrum antibiotic, ciprofloxacin
(Merck) was used as a positive control at a starting concentration
of 0.1 mg/ml. Negative controls (SGF, SIF and DMSO) were
included to assess whether they had any impact on the
antimicrobial activity. Test microorganisms without inhibitor
were included in each assay to ascertain microbial viability. MIC
values were determined at least in duplicate.
2.4. LC-UV-MS analysis
The detection of chemical constituents present in the crude
extracts and simulated gastric fluid and simulated intestinal
fluid products was performed using a Waters Alliance 2690
HPLC system (Phenomenex Aqua C18, 4 u, 250×2 mm)
coupled to a 996 photodiode array (PDA) detector and a Waters
API Qauttro Micro MS detector. The PDA detector was set to
scan a wavelength range of 100–1400 nm. The MS detector was
operated in electron impact mode with the capillary voltage at
3.5 kV, the cone voltage at 15 (positive switching — ES+) and
25 (negative switching— ES−). The flow rate of the HPLC was
0.3 ml/min, the nebuliser flow rate 50 l/h and the desolvation
gas flow rate 380 l/h. The source temperature was 120 °C and
the desolvation temperature 380 °C. The mobile phase used
consisted of 0.1% formic acid (solvent A) and acetonitrile
(solvent B) and gradient elution was used over a 40 min period.
The test samples were dissolved in distilled water to a con-
centration of 50 mg/ml. The Masslynx™ (Version 4.0) software
package and Microsoft® Excel (2003) were used to analyse and
graphically display the results. The LC-MS results confirmedTable 1
Summary of MIC results (mg/ml) for T. camphoratus crude extracts, simulated
microorganisms.
Sample MIC (mg/ml)
Staphylococcus aureus ATCC 25923 Enterococcus faecalis ATCC
Crude W 16 2
SGF W N16 16
SIF W N16 N16
Crude M 2 N16
SGF M N16 N16
SIF M N16 N16
GC N16 N16
IC N16 N16
AC 0.625 μg/ml 2.5 μg/ml
DMSO 16 16
Abbreviations: W — water extract/product; M — methanol extract/product; GC —
antibiotic control (0.1 mg/ml); DMSO — dimethyl sulfoxide control; SGF — simuthe LC-UV results but for the sake of brevity the former is
omitted in further discussions.3. Results and discussion
3.1. T. camphoratus
3.1.1. Antimicrobial activity
Sterile water and broth with bacterial culture exhibited
growth indicating viability of the microorganism. The antibiotic
control, ciprofloxacin, was active against all the test organisms
(Table 1). The wells of the Tryptone Soya broth (TSB) control
column remained clear after incubation indicating sterility of the
TSB. The DMSO/water (1:1) solvent exhibited poor antimi-
crobial activities (16 mg/ml) and did not influence the assay
results. The simulated gastric fluid and simulated intestinal fluid
control samples did not exhibit any antimicrobial activity at the
highest concentration tested (16 mg/ml).
A summary of the MIC results against all the organisms is
displayed in Table 1. The crude methanol and water extracts of
T. camphoratus showed good (2 mg/ml) to poor (N16 mg/ml)
antimicrobial activity against the test microorganisms. Re-
cently, Braithwaite et al. (2008) reported antimicrobial activity
of 2 mg/ml for a methanol extract against S. aureus which
correlates with the result from this study. They also reported
activity of 0.5 mg/ml for the acetone extract, 4 mg/ml for the
essential oil and 0.62 mg/ml for the inhaled smoke fraction. For
the T. camphoratus extracts that exhibited antimicrobial ac-
tivity in this study, the activity decreased in all cases after
exposure to simulated gastric fluid with the exception of the
water extract which remained constant at 8 mg/ml against
E. coli. It can be deduced that on exposure to conditions that are
similar to those in the stomach, the antimicrobially active
compounds are degraded. After exposure to simulated intes-
tinal fluid, no activity was noted for any of the extracts against
any of the microorganisms. This indicates that orally ingested
wild camphor loses all antimicrobial activity when exposed
to conditions similar to those found in the small intestines.
These results lend even more scientific credibility to the use ofgastric fluid and simulated intestinal fluid products against four different
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16 16
simulated gastric fluid control; IC — simulated intestinal fluid control; AC —
lated gastric fluid; SIF — simulated intestinal fluid.
Fig. 1. LC-UV chromatograms for T. camphoratus crude methanol extract and products. (A) Crude extract, (B) simulated gastric fluid product, (C) simulated intestinal
fluid product, (D) simulated gastric fluid control, and (E) simulated intestinal fluid control.
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inhalation therapy as reported by Braithwaite et al. (2008).
3.1.2. LC-UV analysis
The LC-UV chromatograms for the crude methanol extract,
SGF and SIF products and SGF and SIF control samples are
displayed in Fig. 1. Comparing the peak area per compound in
the extract and each of the products it is clear that the chemical
composition of these extracts changed after exposure to simu-
lated gastrointestinal conditions. For example, at retention times
23.56–23.63 min the peak area for the simulated gastric fluid
product was smaller than the crude extract peak area and no
corresponding simulated intestinal fluid product compounds
were detected at these retention times. In the case of simulated
intestinal fluid this compound was degraded to below the
detection limit of the apparatus. At retention times 18.49–18.58Table 2
Summary of MIC results (mg/ml) for A. betulina crude extracts, simulated gastric flu
Sample MIC (mg/ml)
Staphylococcus aureus ATCC 25923 Enterococcus faecalis ATCC
Crude W N16 N16
SGF W N16 N16
SIF W 8 8
Crude M N16 16
SGF W N16 N16
SIF M N16 N16
GC N16 N16
IC N16 N16
AC 1.25 µg/ml 1.25 µg/ml
Abbreviations: W — water extract/product; M — methanol extract/product; GC —
antibiotic control (0.1 mg/ml); control; SGF — simulated gastric fluid; SIF — simuand 21.07–21.16 min the peak area decreased in order from the
crude extract to the simulated gastric fluid product to the
simulated intestinal fluid product. Thus, it can be deduced that
chemical degradation or alteration takes place on exposure to
simulated gastric as well as simulated intestinal fluid.
3.2. A. betulina
3.2.1. Antimicrobial activity
A summary of the MIC results against all the organisms is
displayed in Table 2. The antimicrobial activity for the A.
betulina crude extracts was poor (8–16 mg/ml) against all the
microorganisms. Moolla and Viljoen (2008) reported antimi-
crobial activity of 4 mg/ml for a dichoromethane:methanol (1:1)
extract of A. betulina against S. aureus. The most interesting
result from this study was that the SIF water extract productsid and simulated intestinal fluid products against four different microorganisms.
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simulated gastric fluid control; IC — simulated intestinal fluid control; AC —
lated intestinal fluid.
Fig. 2. LC-UV chromatograms for A. betulina crude water extract and products. (A) Crude extract, (B) simulated gastric fluid product, (C) simulated intestinal fluid
product, (D) simulated gastric fluid control, and (E) simulated intestinal fluid control.
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and E. faecalis while the crude water extract did not display any
antimicrobial activity against these microorganisms. This
suggests that the antimicrobially active constituents display
behaviour similar to that of a pro-drug. Activation of some of
the phytoconstituents only takes place after the extract has been
exposed to an environment similar to that of the small intestines.
3.2.2. LC-UV analysis
Fig. 2 displays the LC-UV chromatograms for the crude water
extract, SGF and SIF products and SGF and SIF control samples.
The peak area values decreased from the crude extract to the
simulated gastric fluid product and further for the simulated
intestinal fluid product for the compounds that eluted at retention
times 18.50–18.55 and 20.05–20.11 min. This implies that more
degradation occurs in the small intestine environment for these
specific constituents, which may have a profound effect on
bioavailability of these constituents. This was noted as the general
trend for most of the extracts. At retention time 21.13–21.21 min
the peak area decreased slightlymore from the crude extract to the
simulated gastric fluid product than from the crude extract to the
simulated intestinal fluid product indicating greater sensitivity
towards simulated gastric fluid or better stability in the intestinal
fluid. This indicates that there would be even less of this
compound available for absorption in the small intestine after
transit through the stomach than if it was protected in the stomach
(by enteric coating for example) and only liberated in the small
intestines. New compounds that were not present in the crude
extract were detected at retention times 24.23 and 25.86min in the
simulated intestinal fluid products. This corresponds to LC-MS
results and it was speculated that these compounds may beresponsible for the antimicrobial activity that is exhibited after
exposure to the simulated intestinal environment.
These results therefore indicate that the chemical composi-
tion and antimicrobial activity was altered after exposure to
simulated gastrointestinal conditions during dissolution studies.
This implies that orally ingested extracts of T. camphoratus and
A. betulina will behave similarly in vivo, highlighting the
importance of investigating the effect of the gastrointestinal
system for all medicinal plants intended for oral administration.
This is one of the first steps towards validating their extensive
use by the public. More importantly, it is evident that results of
published screening assays may lead to overestimation of
antimicrobial activity since the effect of the gastrointestinal
system is not considered. Alternatively, weak antimicrobial
activity noted during a screening assay generally negates further
exploration of a plant or extract which may have been activated
when exposed to gastrointestinal tract conditions.
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